Bronchodilators And Nebulisers
Published on: August 22, 2024
bronchodilators and nebulisers
Article author photo

Poonam Ramker Yadav

Science Enthusiast, Researcher & Published author

Article reviewer photo

Helen McLachlan

MSc Molecular Biology & Pathology of Viruses, Imperial College London

Introduction

Bronchodilators continue to be the primary method of treatment for airway disorders such as asthma and chronic obstructive pulmonary disease (COPD). From a physiological standpoint, the parasympathetic nervous system, which is responsible for promoting relaxation and digestion during stressful situations, regulates the tone of the airway smooth muscles. This regulation occurs through the release of acetylcholine by cholinergic nerve fibres upon stimulation, affecting voluntary movements to some extent. 

It is now widely acknowledged that an increase in vagus nerve activity plays a crucial role in patients with COPD or asthma and seems to be a significant reversible cause of airway obstruction. 

Bronchodilator drugs produce an anti-bronchoconstrictor outcome. In addition, bronchodilators are a special kind of medicine that helps to loosen and widen the passageways in the lungs. These medications mainly target respiratory ailments that are marked by the constriction of the airways, causing a hindrance to free airflow. Conditions like asthma, COPD, and other respiratory disorders are the primary factors behind the prescription of bronchodilators.

A nebuliser is a device which possesses the ability to transform liquid medication into a delicate mist or aerosol. This mist can then be directly inhaled into the lungs. Such a method of delivery proves to be particularly advantageous for individuals with respiratory ailments, who may encounter difficulties when employing traditional inhalers or who require the administration of medication over an extended period. 

Nebulisers primarily serve the purpose of transporting medications into the respiratory system. They are frequently employed to combat asthma, COPD, cystic fibrosis, and other afflictions related to respiration. Moreover, it is worth mentioning that certain nebulisers possess the added functionality of humidifying the air being inhaled. This feature proves beneficial in instances where dry air has the potential to intensify symptoms associated with respiratory conditions. 

Using nebulized saline solutions can assist in the loosening and removal of mucus from the air passages, a particularly beneficial approach in situations marked by excessive mucus production. In instances of urgent need, such as within medical facilities or on emergency vehicles, nebulisers are employed to swiftly administer fast-acting medications to patients undergoing acute respiratory distress.

Nebulisers are­ common medical devices which transform liquid medication into aerosol form. This process occurs in a chambe­r where the drug, usually a solution or suspe­nsion, is added. Various technical methods aid in the­ change from liquid to aerosol form, after which the patie­nt then breathes in this ae­rosolized medication. A face mask or mouthpie­ce attached to the ne­bulizer is used. Normal breathing e­nables the medicine­ to reach the lungs. Regular upke­ep and cleaning of the ne­bulizer parts is nee­ded for its right functioning and to avoid contamination. Health expe­rts also guide patients on correctly using the­ nebuliser and on proper me­dication for beneficial therapy re­sults.

Types of bronchodilators

There are two types of bronchodilators: beta-agonists and anticholinergics. These medications achieve bronchodilation via a variety of mechanisms. 

Beta-agonists stimulate beta-adrenergic receptors, which relaxes smooth muscle in the airways. There are two types of beta-agonists: short-acting (SABAs) and long-acting (LABAs). SABAs work quickly, making them ideal for treating acute bronchoconstriction. They are commonly used as rescue inhalers during asthma attacks. Albuterol and Levalbuterol are two examples. In contrast, LABAs provide sustained bronchodilation and are used to treat respiratory symptoms over time. They are frequently prescribed in combination with inhaled corticosteroids. Examples include Salmeterol and Formoterol. 

Anticholinergics inhibit the actions of acetylcholine, a neurotransmitter that causes bronchoconstriction. There are short-acting medications, such as Ipratropium, which is frequently used in conjunction with SABAs for acute exacerbations of COPD. They work by relaxing the smooth muscles in the airways. Long-acting anticholinergics, including Tiotropium, Aclidinum, and Umeclidinum, provide sustained bronchodilation for maintenance therapy in chronic respiratory conditions. They are typically used once or twice a day.

In some cases, healthcare providers may prescribe a combination of beta-agonists anticholinergics to enhance bronchodilation. For example, a combination inhaler could contain both a LABA and a long-acting anticholinergic. 

Methylxanthines, such as theophylline, were once commonly used as bronchodilators, but their use has declined due to side effects and potential drug interactions. They function by inhibiting phosphodiesterase, resulting in increased levels of cyclic AMP, which relaxes smooth muscle. 

Types of nebulisers

Nebulisers are classified as jet nebulisers, ultrasonic nebulisers, and mesh nebulisers. To begin, jet nebulisers generate a high-velocity jet from compressed air or oxygen, converting liquid medication into a fine mist. These nebulisers typically include a compressor that produces compressed air or oxygen, a nebuliser cup and a mouthpiece or mask for inhaling. They are affordable and widely available. However, they can be noisy and require a longer administration time than other types.

Next, ultrasonic nebulisers use high-frequency vibrations caused by a piezoelectric crystal to convert liquid medication into a fine mist. These nebulisers are typically smaller and quieter than jet nebulisers, and they may not require an external compressor. Ultrasonic nebulisers are effective for delivering a variety of medications and are frequently preferred due to their portability and quiet operation. They provide rapid drug delivery, are efficient, and may require less maintenance than jet nebulisers.

Finally, mesh nebulisers use a vibrating mesh or plate with microscopic holes to disperse liquid medication. These nebulisers are typically small and portable, with few moving parts. Mesh nebulisers are effective at delivering medications in a short period of time, making them ideal for portable use. They are often quieter, more portable, and deliver drugs faster than other types. However, they might be more expensive. Regular maintenance and cleaning of nebulisers is required to ensure proper operation and prevent widespread contamination.

Indications for bronchodilator use

Bronchodilators are commonly used in the treatment of respiratory conditions characterised by reversible airway obstruction. Here are a few situations where bronchodilators are used:

  • Asthma is a chronic inflammatory condition of the airways that causes bronchoconstriction, resulting in wheezing, shortness of breath, and coughing. SABAs are frequently used as rescue medications to treat acute bronchoconstriction during asthma attacks. When used in conjunction with inhaled corticosteroids, LABAs can provide long-term control
  • COPD, which includes chronic bronchitis and emphysema, is defined by persistent airflow limitation and bronchoconstriction. Short-acting and long-acting bronchodilators, such as beta-agonists and anticholinergics, are commonly used to treat COPD symptoms and improve quality of life.
  • Some people develop bronchoconstriction during or after exercise. SABAs are frequently used before exercise to prevent or treat exercise-induced bronchoconstriction. This is especially common in people with asthma.
  • Bronchoconstriction can cause respiratory distress in emergency situations like acute asthma or severe COPD exacerbations. In emergency situations, nebulized or inhaled bronchodilators, particularly SABAs and anticholinergics, are used to quickly dilate the airways and improve breathing. 
  • Bronchodilators can be used before surgery or certain diagnostic procedures to avoid or reduce bronchoconstriction caused by anaesthesia or other triggers. Short-acting bronchodilators may be used prior to such procedures to ensure proper airway function.
  • Respiratory infections, particularly in people with pre-existing respiratory conditions, can cause bronchoconstriction. Bronchodilators may be used to treat bronchoconstriction and improve breathing during respiratory infections.

Follow your doctor’s instructions for the proper dosage of the bronchodilator. Use only the amount of medication prescribed, no more or less. Administer bronchodilators as directed by your healthcare professional. Some bronchodilators are used as needed to treat acute symptoms, while others may be part of a daily routine. If you miss a scheduled dose, do not take an additional dose without first consulting your healthcare provider. 

Common bronchodilator side effects include jitteriness, increased heart rate, and mild tremors. These effects are typically transient. Inform your doctor if you have persistent or severe side effects. If you develop symptoms of an allergic reaction (such as a rash, itching, swelling, severe dizziness, or difficulty breathing), seek medical attention immediately.

If you have a history of certain medical conditions, such as heart disease, hypertension, or hyperthyroidism, notify your doctor. People who are pregnant or breastfeeding should talk to their doctor about the risks and benefits of using bronchodilators. Monitor your symptoms on a regular basis and notify your doctor if they change. Keep track of peak flow measurements and other indicators as directed by your healthcare provider.

Summary

Bronchodilators are essential treatments for respiratory disorders like asthma and COPD, aimed at widening airways to improve airflow. They work by targeting airway smooth muscle relaxation through two main types: beta-agonists and anticholinergics. Beta-agonists, including short-acting (SABAs) and long-acting (LABAs) types, quickly relieve acute bronchoconstriction and provide sustained relief, respectively. Anticholinergics, both short-acting and long-acting, inhibit acetylcholine to ease airway constriction.

Nebulisers are devices that convert liquid medication into an aerosol for direct inhalation, aiding those who struggle with traditional inhalers or need prolonged medication. They come in three types: jet, ultrasonic, and mesh nebulisers, each with distinct features regarding noise, size, and efficiency.

Bronchodilators are prescribed for conditions such as asthma, COPD, exercise-induced bronchoconstriction, and acute respiratory distress. It's crucial to follow prescribed dosages and instructions, monitor for side effects, and consult healthcare providers for proper management and adjustments, especially if underlying health conditions are present.

References

  1. Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and Therapeutics of Bronchodilators. Pharmacol Rev 2012;64:450–504. https://doi.org/10.1124/pr.111.004580.
  2. Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. The Journal of Pediatrics 1987;111:278–82. https://doi.org/10.1016/S0022-3476(87)80087-2.
  3. Csonka P, Tapiainen T, Mäkelä MJ, Lehtimäki L. Optimal administration of bronchodilators with valved holding chambers in preschool children: a review of literature. Eur J Pediatr 2021;180:3101–9. https://doi.org/10.1007/s00431-021-04074-3.
  4. Barnes PJ. Chronic Obstructive Pulmonary Disease. Reference Module in Biomedical Sciences, Elsevier; 2014, p. B9780128012383000258. https://doi.org/10.1016/B978-0-12-801238-3.00025-8.
  5. Holgate ST, Thomas M. Asthma. Middleton’s Allergy Essentials, Elsevier; 2017, p. 151–204. https://doi.org/10.1016/B978-0-323-37579-5.00007-6.
  6. Goggs RAN, Boag AK. Aspiration Pneumonitis and Pneumonia. Small Animal Critical Care Medicine, Elsevier; 2015, p. 127–33. https://doi.org/10.1016/B978-1-4557-0306-7.00023-4.
  7. Couetil LL. Inflammatory diseases of the lower airway of athletic horses. Equine Sports Medicine and Surgery, Elsevier; 2014, p. 605–32. https://doi.org/10.1016/B978-0-7020-4771-8.00028-4.
  8. Creer TL, Levstek DA. Respiratory Disorders. Comprehensive Clinical Psychology, Elsevier; 1998, p. 339–59. https://doi.org/10.1016/B0080-4270(73)00092-4.
  9. Kirby M. Hyperpolarized 3He Gas MRI Studies of Pulmonary Disease. Hyperpolarized and Inert Gas MRI, Elsevier; 2017, p. 71–88. https://doi.org/10.1016/B978-0-12-803675-4.00005-1.
  10. Almadhoun K, Sharma S. Bronchodilators. StatPearls, Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519028/
  11. Matera MG, Page CP, Calzetta L, Rogliani P, Cazzola M. Pharmacology and Therapeutics of Bronchodilators Revisited. Pharmacol Rev 2020;72:218–52. https://doi.org/10.1124/pr.119.018150.
  12. Nelson HS. β-Adrenergic Bronchodilators. N Engl J Med 1995;333:499–507. https://doi.org/10.1056/NEJM199508243330807.
  13. Cazzola M, Matera MG. Emerging inhaled bronchodilators: an update. European Respiratory Journal 2009;34:757–69. https://doi.org/10.1183/09031936.00013109.
Share

Poonam Ramker Yadav

Science Enthusiast, Researcher & Published author
India, UK

Poonam. a versatile individual, is known for their passion and commitment to Science and books. With a strong foundation in research, they have demonstrated a remarkable ability to excel in their endeavors.
Her love for learning has led to remarkable experiences and achievements, demonstrating their determination and dedication.

arrow-right